These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31399001)

  • 1. Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis.
    Lapinskas PJ; Ben-Harari RR
    Postgrad Med; 2019 Nov; 131(8):589-596. PubMed ID: 31399001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
    Brun-Pascaud M; Chau F; Garry L; Jacobus D; Derouin F; Girard PM
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2067-70. PubMed ID: 8878582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
    Mui EJ; Schiehser GA; Milhous WK; Hsu H; Roberts CW; Kirisits M; Muench S; Rice D; Dubey JP; Fowble JW; Rathod PK; Queener SF; Liu SR; Jacobus DP; McLeod R
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e190. PubMed ID: 18320016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase.
    Reynolds MG; Oh J; Roos DS
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1271-7. PubMed ID: 11257045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-toxoplasmosis drugs.
    Derouin F
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1368-74. PubMed ID: 11890349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
    J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis.
    Hopper AT; Brockman A; Wise A; Gould J; Barks J; Radke JB; Sibley LD; Zou Y; Thomas S
    J Med Chem; 2019 Feb; 62(3):1562-1576. PubMed ID: 30624926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
    Rutaganira FU; Barks J; Dhason MS; Wang Q; Lopez MS; Long S; Radke JB; Jones NG; Maddirala AR; Janetka JW; El Bakkouri M; Hui R; Shokat KM; Sibley LD
    J Med Chem; 2017 Dec; 60(24):9976-9989. PubMed ID: 28933846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A; Papoulis AT; Forsch RA; Queener SF
    J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting DHFR in parasitic protozoa.
    Anderson AC
    Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis.
    Moine E; Moiré N; Dimier-Poisson I; Brunet K; Couet W; Colas C; Van Langendonck N; Enguehard-Gueiffier C; Gueiffier A; Héraut B; Denevault-Sabourin C; Debierre-Grockiego F
    Int J Parasitol; 2018 Jun; 48(7):561-568. PubMed ID: 29524527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection.
    Doggett JS; Ojo KK; Fan E; Maly DJ; Van Voorhis WC
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3547-9. PubMed ID: 24687502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Insight into Effective Inhibitors' Binding to
    Vanichtanankul J; Yoomuang A; Taweechai S; Saeyang T; Pengon J; Yuvaniyama J; Tarnchompoo B; Yuthavong Y; Kamchonwongpaisan S
    ACS Chem Biol; 2022 Jul; 17(7):1691-1702. PubMed ID: 35715223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
    Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antibacterials for the treatment of toxoplasmosis; a patent review.
    Rodriguez JB; Szajnman SH
    Expert Opin Ther Pat; 2012 Mar; 22(3):311-33. PubMed ID: 22404108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.
    Neville AJ; Zach SJ; Wang X; Larson JJ; Judge AK; Davis LA; Vennerstrom JL; Davis PH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7161-9. PubMed ID: 26392504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human toxoplasmosis-Searching for novel chemotherapeutics.
    Antczak M; Dzitko K; Długońska H
    Biomed Pharmacother; 2016 Aug; 82():677-84. PubMed ID: 27470411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knocking down of the DHFR-TS gene in Toxoplasma gondii using siRNA and assessing the subsequences on toxoplasmosis in mice.
    Azimi-Resketi M; Eskandarian A; Ganjalikhani-Hakemi M; Zohrabi T
    Acta Trop; 2020 Jul; 207():105488. PubMed ID: 32277926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Nigella sativa oil on experimental toxoplasmosis.
    Mady RF; El-Hadidy W; Elachy S
    Parasitol Res; 2016 Jan; 115(1):379-90. PubMed ID: 26446086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.